Xenon Pharmaceuticals Inc.
Director/Senior Director, Investor Relations
Xenon Pharmaceuticals Inc., Boston, Massachusetts, United States, 02298
Director/Senior Director, Investor Relations
Boston, MA, USA
Job Description Posted Friday, November 7, 2025 at 11:00 AM
Who We Are:
Xenon Pharmaceuticals ( NASDAQ:XENE ) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life‑changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
What We Do:
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced, clinically validated potassium channel modulator in late‑stage clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b “X‑TOLE” study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic‑clonic seizures. In August 2025, we announced the complementation of patient recruitment in our Phase 3 X‑TOLE2 study and topline data are anticipated in early 2026. We also have multiple Phase 3 azetukalner clinical trials in major depressive disorder (MDD) and bipolar depression (BPD) underway, based on topline data from our Phase 2 “X‑NOVA” clinical trial. In addition, we are proud of the leading‑edge science coming out of our discovery labs, including early‑stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates, and have recently initiated Phase 1 studies for our follow‑on Kv7 channel opener, XEN1120, and our lead Nav1.7 development candidate, XEN1701, in pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
About the Role:
We are seeking a
Director/Senior Director, Investor Relations
to join our team. This individual will partner with the CEO and CFO to develop and execute the investor relations strategy, manage relationships with investors and analysts, and effectively communicate our scientific, clinical, and financial progress to the investment community. This role will work closely with the Senior Executive Team, and Corporate Affairs, Development, Commercial, Finance, and Legal departments to maintain an in‑depth understanding of the company’s operations, financial performance, and strategies. The ideal candidate is a strong communicator who collaborates effectively with key functions to communicate the corporate story.
This is a high‑impact role ideal for an IR professional who thrives in a dynamic, fast‑paced biotech environment and can bridge science, strategy, and finance. This position reports to the Chief Financial Officer and will be based out of Boston, MA, USA in our Needham office. The level of the position will be commensurate with the candidate’s education and industry experience. This role is a hybrid position, requiring a minimum of 2 days per week in the office.
RESPONSIBILITIES:
Work with CEO and CFO to develop annual and longer‑term strategic investor relations plans to communicate the company’s strategies and progress to the investment community.
Manage the company’s participation in banking conferences, non‑deal roadshows, and analyst/investor days through effective project management and relationship management strategies.
Collaborate with the CFO, CEO, corporate affairs and senior executive team to craft clear, consistent messaging around company strategy, pipeline, and milestones.
Partner with corporate affairs and legal teams to ensure all external communications are accurate and consistent with corporate messaging including presentation decks, news releases, and all other content.
Drive and support preparation of earnings calls, press releases, and SEC filings (10‑K, 10‑Q, 8‑K) in coordination with Finance and Legal.
Lead development of briefing materials for management in preparation for investor meetings.
Support the CEO and CFO in providing timely, consistent, compliant, and accurate responses; maintain database of interactions; and convey sentiments and feedback to management.
Track and analyze insights on market dynamics, shareholder composition, and competitive positioning. Analyst models, reports, and stock performance.
Work closely with CEO and CFO to establish the optimal mix of shareholders through targeting initiatives.
Work with Competitive Intelligence leader and other leaders across the company to monitor competitors’ performance – along with industry, regulatory, and other relevant trends – to inform differentiated corporate messaging.
Support the development and execution of the company’s financing strategy.
Collaborate on execution of the annual meeting of shareholders together with the Legal, Finance, and Corporate Affairs teams.
Develop and propose short‑ and long‑term goals for the Investor Relations function in accordance with overall company strategies.
Plan and manage budget proposals and approved budgets in accordance with the company’s strategic and operating plans and Finance policies.
Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any.
Travel will be required.
Other duties as assigned.
QUALIFICATIONS:
Bachelor’s degree or equivalent, ideally with a specialization in Finance, Business, Life Sciences, or Communications; master’s or advanced degree preferred.
Biotech or pharma industry experience is required; 8+ years of investor relations experience, ideally in the healthcare sector.
Proven track record of developing positive long‑term relations with analysts and the investor community.
Deep understanding of capital markets and the financial statements and valuation models used by investors and analysts.
Experience developing executive level communications and engaging directly with senior management.
Superior interpersonal and relationship management skills.
Excellent oral and written communication skills.
Knowledge of Regulation FD and SEC reporting requirements impacting investor and other external communications.
Outstanding organizational skills and attention to detail.
Highly collaborative working style across internal and external teams.
The base salary range for this role is
$219,000 to $283,900 USD ; we will consider above this range for exceptional candidates. Base salary is determined by a combination of factors including, but not limited to, education and other qualifications, years of relevant experience, and internal equity.
Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short- & long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions. Xenon encourages time to rest and re‑charge through vacation, personal days, sick days, and an end‑of‑year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees. As part of our hiring process, Xenon conducts background checks for finalist candidates. The types of checks conducted will vary depending on the relevance to the position. US positions only: Xenon Pharmaceuticals USA Inc. participates in the E‑Verify program in all states in which we hire. Learn more about the E‑Verify program here . To apply for this position, click Apply Now to complete the application. We thank all applicants for their interest; however, due to the volume of applicants, only those chosen for interview will be contacted.
#J-18808-Ljbffr
Job Description Posted Friday, November 7, 2025 at 11:00 AM
Who We Are:
Xenon Pharmaceuticals ( NASDAQ:XENE ) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life‑changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
What We Do:
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced, clinically validated potassium channel modulator in late‑stage clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b “X‑TOLE” study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic‑clonic seizures. In August 2025, we announced the complementation of patient recruitment in our Phase 3 X‑TOLE2 study and topline data are anticipated in early 2026. We also have multiple Phase 3 azetukalner clinical trials in major depressive disorder (MDD) and bipolar depression (BPD) underway, based on topline data from our Phase 2 “X‑NOVA” clinical trial. In addition, we are proud of the leading‑edge science coming out of our discovery labs, including early‑stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates, and have recently initiated Phase 1 studies for our follow‑on Kv7 channel opener, XEN1120, and our lead Nav1.7 development candidate, XEN1701, in pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
About the Role:
We are seeking a
Director/Senior Director, Investor Relations
to join our team. This individual will partner with the CEO and CFO to develop and execute the investor relations strategy, manage relationships with investors and analysts, and effectively communicate our scientific, clinical, and financial progress to the investment community. This role will work closely with the Senior Executive Team, and Corporate Affairs, Development, Commercial, Finance, and Legal departments to maintain an in‑depth understanding of the company’s operations, financial performance, and strategies. The ideal candidate is a strong communicator who collaborates effectively with key functions to communicate the corporate story.
This is a high‑impact role ideal for an IR professional who thrives in a dynamic, fast‑paced biotech environment and can bridge science, strategy, and finance. This position reports to the Chief Financial Officer and will be based out of Boston, MA, USA in our Needham office. The level of the position will be commensurate with the candidate’s education and industry experience. This role is a hybrid position, requiring a minimum of 2 days per week in the office.
RESPONSIBILITIES:
Work with CEO and CFO to develop annual and longer‑term strategic investor relations plans to communicate the company’s strategies and progress to the investment community.
Manage the company’s participation in banking conferences, non‑deal roadshows, and analyst/investor days through effective project management and relationship management strategies.
Collaborate with the CFO, CEO, corporate affairs and senior executive team to craft clear, consistent messaging around company strategy, pipeline, and milestones.
Partner with corporate affairs and legal teams to ensure all external communications are accurate and consistent with corporate messaging including presentation decks, news releases, and all other content.
Drive and support preparation of earnings calls, press releases, and SEC filings (10‑K, 10‑Q, 8‑K) in coordination with Finance and Legal.
Lead development of briefing materials for management in preparation for investor meetings.
Support the CEO and CFO in providing timely, consistent, compliant, and accurate responses; maintain database of interactions; and convey sentiments and feedback to management.
Track and analyze insights on market dynamics, shareholder composition, and competitive positioning. Analyst models, reports, and stock performance.
Work closely with CEO and CFO to establish the optimal mix of shareholders through targeting initiatives.
Work with Competitive Intelligence leader and other leaders across the company to monitor competitors’ performance – along with industry, regulatory, and other relevant trends – to inform differentiated corporate messaging.
Support the development and execution of the company’s financing strategy.
Collaborate on execution of the annual meeting of shareholders together with the Legal, Finance, and Corporate Affairs teams.
Develop and propose short‑ and long‑term goals for the Investor Relations function in accordance with overall company strategies.
Plan and manage budget proposals and approved budgets in accordance with the company’s strategic and operating plans and Finance policies.
Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any.
Travel will be required.
Other duties as assigned.
QUALIFICATIONS:
Bachelor’s degree or equivalent, ideally with a specialization in Finance, Business, Life Sciences, or Communications; master’s or advanced degree preferred.
Biotech or pharma industry experience is required; 8+ years of investor relations experience, ideally in the healthcare sector.
Proven track record of developing positive long‑term relations with analysts and the investor community.
Deep understanding of capital markets and the financial statements and valuation models used by investors and analysts.
Experience developing executive level communications and engaging directly with senior management.
Superior interpersonal and relationship management skills.
Excellent oral and written communication skills.
Knowledge of Regulation FD and SEC reporting requirements impacting investor and other external communications.
Outstanding organizational skills and attention to detail.
Highly collaborative working style across internal and external teams.
The base salary range for this role is
$219,000 to $283,900 USD ; we will consider above this range for exceptional candidates. Base salary is determined by a combination of factors including, but not limited to, education and other qualifications, years of relevant experience, and internal equity.
Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short- & long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions. Xenon encourages time to rest and re‑charge through vacation, personal days, sick days, and an end‑of‑year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees. As part of our hiring process, Xenon conducts background checks for finalist candidates. The types of checks conducted will vary depending on the relevance to the position. US positions only: Xenon Pharmaceuticals USA Inc. participates in the E‑Verify program in all states in which we hire. Learn more about the E‑Verify program here . To apply for this position, click Apply Now to complete the application. We thank all applicants for their interest; however, due to the volume of applicants, only those chosen for interview will be contacted.
#J-18808-Ljbffr